Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study - Top-Institutions - MDSpire

Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study

By
Kimberly A Brown
Stuart C Gordon
Yichu Wang
Trueman Wu
Sheri Trudeau
Loralee B Rupp
Yihe G Daida
Mark A Schmidt
Mei Lu
March 27, 2026

Bmj Open Gastroenterology

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

#1

Chronic Hepatitis Cohort Study (CHeCS)

N/A, N/A
Key Differentiators
- Hepatology
#2

Geisinger Health System

Danville, Pennsylvania
Key Differentiators
- Hepatology
#3

Henry Ford Health System

Detroit, Michigan
Key Differentiators
- Hepatology
#4

Kaiser Permanente Hawai’i

Honolulu, Hawaii
Key Differentiators
- Hepatology
#5

Kaiser Permanente Northwest

Portland, Oregon
Key Differentiators
- Hepatology

Original Source(s)

Bmj Open Gastroenterology

Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study

by Kimberly A Brown, Stuart C Gordon, Yichu Wang, Trueman Wu, Sheri Trudeau, Loralee B Rupp, Yihe G Daida, Mark A Schmidt, Mei Lu
March 27, 2026

Related Content

Bmj Open Gastroenterology

Interplay between MASLD, obesity and type 2 diabetes: epidemiology, shared pathways and clinical implications

by Kenneth Tachi, Adwoa Agyei-Nkansah, Yacoba Atiase, Bright Forkuo, Victoria Akosua Agyen-Frimpong
July 2, 2026

Frontiers In Endocrinology

Cytokeratin-18 increase as a signal for early liver cell changes in high-fat diet-induced obesity before overt steatohepatitis

Frontiers In Immunology

Unexpected genetically determined immune dysregulation with liver involvement: GIMAP5 therapeutic dilemmas between targeted therapy and HSCT